A comparison of angiotensin-converting enzyme inhibitor and Angiotensin II type 1 receptor blocker on carotid artery intima and media thickness in hypertensives

被引：0
|
作者：
Uchiyama-Tanaka, Y [1 ]
Matsubara, H [1 ]
Mori, Y [1 ]
Murasawa, S [1 ]
Shibasaki, Y [1 ]
Iwasaka, T [1 ]
机构：
[1] Kansai Med Univ, Dept Med 2, Moriguchi, Osaka 570, Japan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：241A / 241A
页数：1
相关论文
共 50 条
  • [1] Effect of polymorphisms of the angiotensin-converting enzyme and apolipoprotein E on carotid intima media thickness in untreated hypertensives
    Hernández, SAR
    Kroon, AA
    van Boxtel, MPJ
    Spiering, W
    Mess, WH
    de Leeuw, PW
    JOURNAL OF HYPERTENSION, 2003, 21 : S98 - S98
  • [2] Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection
    Hou, Fan Fan
    Zhou, Qiu Gen
    NEPHROLOGY, 2010, 15 : 57 - 60
  • [3] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [4] Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide
    Sata, N
    Tanaka, Y
    Suzuki, S
    Kamimura, R
    Mifune, H
    Nakamura, K
    Miyahara, K
    Arima, T
    CIRCULATION JOURNAL, 2003, 67 (12) : 1053 - 1058
  • [5] Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
    Jun, Hye-Ran
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [6] Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
    Zhang, Chao
    Zhong, Jun
    Chen, Wei-Xiang
    Zhang, Xu-Yang
    Li, Yu-Hong
    Zhou, Teng-Yuan
    Zou, Yong-Jie
    Lan, Chuan
    Li, Lan
    Lai, Zhao-Pan
    Feng, Hua
    Hu, Rong
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 355 - 363
  • [7] Paradoxical pressor response with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Sabitha, P.
    Adhikari, Prabha M.
    AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (07): : 364 - +
  • [8] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [9] Effects of aliskiren on the fibrinolytic system in patients with coronary artery disease receiving angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor blocker
    Ishibashi, Ken
    Kurisu, Satoshi
    Kato, Yasuko
    Mitsuba, Naoya
    Dohi, Yoshihiro
    Nishioka, Kenji
    Kihara, Yasuki
    HEART AND VESSELS, 2013, 28 (01) : 7 - 11
  • [10] Effects of aliskiren on the fibrinolytic system in patients with coronary artery disease receiving angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor blocker
    Ken Ishibashi
    Satoshi Kurisu
    Yasuko Kato
    Naoya Mitsuba
    Yoshihiro Dohi
    Kenji Nishioka
    Yasuki Kihara
    Heart and Vessels, 2013, 28 : 7 - 11
12345